A fertility player based in the US with a diagnostic technology platform engaged Treehill for corporate and product development.
The company’s diagnostic platform held a well-established proof-of-concept in fertility. This proof-of-concept data indicated significant commercial promise. However, the platform was owned by a biotech company that focused on other indications.
Orchestrate a carve-out of the diagnostic platform from the biotech and house the technology in a separate NewCo.
Build a dedicated leadership team with relevant cross-functional expertise and domain experience.
Create strong commercial industry relationships and redesign the go-to-market strategy.
Design and implement a new clinical and regulatory asset development plan.
Stand-alone IVF diagnostic player with strategy & capabilities for commercialization & financing.
Orchestrate a carve-out of the diagnostic platform from the biotech and house the technology in a separate NewCo.
Build a dedicated leadership team with relevant cross-functional expertise and domain experience.
Build a dedicated leadership team with relevant cross-functional expertise and domain experience.
Build a dedicated leadership team with relevant cross-functional expertise and domain experience.
Orchestrate a carve-out of the diagnostic platform from the biotech and house the technology in a separate NewCo.
Build a dedicated leadership team with relevant cross-functional expertise and domain experience.
Create strong commercial industry relationships and redesign the go-to-market strategy.
Design and implement a new clinical and regulatory asset development plan.
